 NORTHBROOK, Ill., March 29, 2022 GLOBE NEWSWIRE -- Clarus Therapeutics Holdings, Inc. Clarus Nasdaq:CRXT, a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced it will release its fourth quarter and full year 2021 financial and operating results on Wednesday, March 30, 2022, after the market closes. 